CpG immunostimulatory sequences enhance contact hypersensitivity responses in mice

Area of Science:

• Immunology
• Dermatology
• Vaccinology

Background:

• Bacterial DNA and synthetic CpG oligodeoxynucleotides (ODN) activate dendritic cells (DC), leading to their consideration as vaccine adjuvants.
• Despite their proposed safety, the potential for CpG ODN to induce adverse immune reactions requires further investigation.

Purpose of the Study:

• To investigate the effect of CpG ODN on antigen-specific skin inflammatory reactions.
• To determine if CpG ODN can exacerbate T cell-mediated skin diseases.

Main Methods:

• Utilized a murine model of contact hypersensitivity (CHS) to 2,4-dinitrofluorobenzene (DNFB).
• Administered CpG ODN subcutaneously prior to DNFB sensitization and challenge.
• Assessed CHS response severity, CD8+ T cell recruitment, and DC activation markers (MHC class II, CD80, CD86).

Main Results:

• Subcutaneous CpG ODN injection significantly enhanced the DNFB-specific CHS response.
• CpG ODN treatment led to increased recruitment of CD8+ T cells at challenge sites.
• Enhanced CHS was linked to upregulated DC maturation markers and improved antigen presentation by treated DCs.

Conclusions:

• CpG ODN can potentiate antigen-specific skin inflammatory reactions, particularly T cell-mediated responses.
• The adjuvant properties of CpG ODN may be associated with adverse immune side-effects, including the exacerbation of skin diseases.
• CpG ODN's local enhancement of DC function contributes to heightened inflammatory responses.